**Introduction:** Joint hypermobility syndrome is a common disorder, particularly in childhood. Patients often develop other symptoms of autonomic dysfunction and widespread pain. This case describes a lady with longstanding hypermobility who developed worsening symptoms after a long period of stability. It illustrates the main features of the syndrome as well as management. Treatment can be challenging and requires multidisciplinary involvement in order to preserve function and prevent deconditioning.

**Case description:** Ms H, a 36 year old lady presented with an eight month history of widespread joint pain. She had a long history of hypermobility, having been diagnosed as a child. During her pregnancy 9 years ago her joints became much more painful and she suffered with muscle spasms in her lower back and buttocks. This settled after her pregnancy with physiotherapy and simple analgesia. Six months ago her pain worsened significantly. She developed constant pain in her knees and ankles and had sustained a couple of falls due to frequent ankle inversion. She also had significant lower back pain. She had difficulty in completing the exercises given by physiotherapy. She had a history of previous dislocations of the thumbs. In the last few months she had also developed frequent headaches. She reported poor sleep and recent low mood with frequent episodes of tearfulness. She was finding it increasingly difficult to complete her usual daily activities. She had been working as a healthcare assistant in Day Surgery but had been on sick leave for a few months. She had tried a phased return a few weeks ago but was unable to continue. Her past medical history included mild asthma treated with salbutamol inhalers as required and polycystic ovary syndrome. Her current medications were: codeine phosphate 60mg qds, gabapentin 1200mg tds, naproxen 500mg bd, paracetamol 1g qds, morphine sulphate liquid 10/5ml 2.5mg nocte. There were no known allergies. She was an ex-smoker having stopped a year ago. She rarely drinks alcohol, with a maximum of 2 units per week. She lived at home with her husband and 9 year old son. On examination, she was overweight with a BMI of 30. She was hypermobile with a Beighton score of 8/9 (knees, elbows, wrists, fingers bilaterally). Her lumbar spine movements were normal with a Schober's test of 7cm on flexion. There was no synovitis or enthesitis. There were no rashes, no psoriatic skin or nail disease and no lymphadenopathy. Her lying/standing blood pressure was normal. Her vitamin D level 3 months ago, checked by the GP was low at 26.7 nmol/L with a normal PTH of 2.76 pmol/L. RHF was slightly raised at 22 and anti-CCP antibody was negative. ANA, ENA and ACE were negative. Her inflammatory markers were normal with CRP 5 and ESR 7mm/hr. Urinalysis was normal. X-rays of her hands, feet and ankles were normal. MRI of the spine showed a reduction in cervical lordosis and normal thoracic and lumbar alighnment. No areas of bone marrow oedema demonstrated to suggest an active inflammatory spondyloarthropathy. Vertebral body height well preserved. There was no evidence of scoliosis. She was referred to physiotherapy for stretching and strengthening exercises in particular core strengthening. Sleep hygiene was discussed. Amitriptyline 10mg 2 hours before bedtime was added and titrated to a maximum of 50 mg. Her vitamin D was replaced with a course of Desunin 1600 IU daily. She was advised to lose weight. Possible treatment options for her low mood were discussed including psychological and pharmacological therapy. She chose to pursue self-referral to community psychology through IAPT (Improving Access to Psychological Therapies).

**Discussion:** Benign joint hypermobility syndrome (JHS) has until recently, been classified as Type III Ehler's-Danlos Syndrome. It is characterised by generalised hypermobility of the joints without any defined molecular basis. Joint hypermobility is common, occurring in around 10% of the population, with a higher prevalence in childhood. Autonomic features are also commonly seen in patients with JHS. This includes downregulated metabolism, blood pressure instability, and gastrointestinal dysfunction. The overwhelming problem for most patients is pain. Chronic pain is more prevalent in JHS than in classical Ehler's-Danlos Syndrome. The severity of pain is correlated with the degree of hypermobility, dislocations and previous surgery. Pain is associated with poor quality sleep and functional impairment in activities of daily living. The development of chronic pain is related to a combination of anxiety, physical deconditioning, joint instability and central nervous system sensitisation. Psychosocial factors have a significant effect on the course of musculoskeletal pain. Pain and function are not necessarily related to the Beighton score and degree of hypermobility. Within the population of JHS, psychosocial factors are more common and need to be addressed in order to improve function (Scheper et al 2015). Chronic pain leads to fear-avoidance, catastrophising and kinesophobia (fear of movement) with a perpetuating cycle of pain leading to inactivity resulting in reduced function. The joints most commonly affected in JHS are the knees and ankles as in this case. This patient also demonstrated evidence of widespread pain and generalised hyperalgesia. This is a feature of central sensitisation: augmentation of central pain processing. This is reflected in lower pain pressure thresholds and widespread hyperalgesia at non-joint sites as well as over joints. Central sensitisation is also reflected in a reduced efficacy of lidocaine induced analgesia and the relatively reduced efficacy of morphine based analgesia.

**Key learning points:** 1. Joint hypermobility is common. While most cases are due to benign joint hypermobility, rare underlying causes and other heritable disorders of connective tissue disease must be considered. These include osteogenesis imperfecta, Marfans's syndrome, Ehler's-Danlos Syndrome and Loeys-Dietz syndrome (Colombi et al 2015). 2. The classification for Ehler's Danlos Syndrome, including joint hypermobility syndrome has recently been updated 3. Joint hypermobility syndrome is a diagnosis of exclusion and requires multidisciplinary management in order to improve and maintain function. It is also important to demedicalise the syndrome and aim towards improving function.
